Weight loss treatments for adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a BMI of 27 or higher (or a BMI of 27–30 with a weight-related health problem like high blood pressure or diabetes).
- Your weight must not have changed by more than 5% in the last 3 months (no major gains or losses).
- You cannot have had weight-loss surgery, except liposuction or tummy tuck done more than a year ago.
- You must not have type 1 diabetes, a history of diabetic coma, or poorly controlled high blood pressure.
- You must not have liver disease (except nonalcoholic fatty liver), gallbladder problems in the last 2 years, or a past suicide attempt.
- You must not have had a heart attack, stroke, unstable chest pain, or heart failure hospitalization in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study tests a new medication (LY4174794) for weight loss in people who are overweight or have obesity. It will help see if the drug is safe and how the body processes it.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.